Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-90
SponsorHebrew SeniorLife
About this trial
The objective of this study is to determine the effects of a 6-month, home-based personalized transcranial direct current stimulation (tDCS) intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in older adults with motoric cognitive risk syndrome (MCR).
Eligibility criteria
Qualifiers
Men and women
Age 65-90 years
Subjective cognitive complaints as defined by a 'Yes' response to "Do you feel that you have more problems with memory than most?" or a 'No' response to "is your mind as clear as it used to be?"
Montreal Cognitive Assessment (MoCA) score ≥21
Disqualifiers
Formal education less than the 8th grade
Previous physician diagnosis of dementia
Any current diagnosis of a major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depressive disorder)
Evidence of moderate-to-severe depressive symptoms defined by a score of ≥9 on the 15-item Geriatric Depression Scale
Trial design
Treatments tested in this trial
- Personalized Transcranial Direct Current Stimulation (tDCS)
- Active-Sham
Treatment groups
128 Participants
are divided into 2 treatment groupsSponsors and collaborators
Hebrew SeniorLife
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Tel Aviv Medical Center
Collaborator
Source ClinicalTrials.gov